CHINA – Nestlé has inaugurated two new factories in the China Medical City in Taizhou, a US$150 million investment to meet the needs of consumers for Foods for Special Medical Purposes (FSMP) and skin care products.

This investment for the new factories of Nestlé Health Science and Nestlé Skin Health adds to Nestlé’s existing production set up and underscores the company’s confidence in the future prospects of the Chinese market.

The two state-of-the-art factories, built on 13 ha area, utilize best-in-class technologies to ensure the highest levels of quality assurance and manufacturing efficiency.

They will also contribute to the development of the local economy through local production.

“Nestlé is fully committed to continue to invest to support sustainable growth in China.

By bringing the manufacturing capabilities of Nestlé Health Science and Nestlé Skin Health to China, we are in a stronger position to enhance Nestlé’s product offering and meet consumer expectations,” said Magdi Batato, Executive Vice President, Head of Operations for Nestlé S.A.

Nestlé has identified consumer healthcare as an addition growth platform, complementary to its core food and beverage business.

The new investment underscores Nestlé’s purpose to enhance quality of life and contribute to healthier future.

“These new factories significantly strengthen Nestlé’s product and services offering to serve consumers in China.

They underscore Nestlé’s commitment to nutrition, health and wellness, which is fully in line with government’s priority to build a healthier population in China,” said Rashid Qureshi, Chairman and CEO of Nestlé Greater China.

Liu Xuecong, secretary general of the China Nutritional and Health Food Association also said: “The FSMP industry is expected to become the new blue ocean for China’s health industry.

Nestlé Taizhou factory is scientifically and technologically advanced and will undoubtedly play an important role in supporting the healthy development of China’s FSMP industry.”